中国科学家探索脑机接口技术造福更多病患

Core Insights - Brain-computer interface (BCI) technology is advancing rapidly, with applications in rehabilitation for stroke patients and other neurological conditions [1][2] - The establishment of the first comprehensive clinical trial area for BCI in China marks a significant step towards integrating this technology into everyday medical practice [1][2] - China's BCI technology is positioned for global leadership due to supportive policies and technological breakthroughs [2] Group 1: Technological Advancements - BCI technology enables the collection of brain signals and their conversion into specific commands, facilitating communication between the brain and external devices [1] - The Tianjin University BCI laboratory has developed a proprietary decoding chip, "Brain Speaker," which is the first of its kind globally [4] - Non-invasive BCI technology is a focus area for Tianjin University, with applications in manned spaceflight, medical education, and clinical rehabilitation [2][4] Group 2: Market Potential - McKinsey predicts that the potential market for BCI in serious medical applications could reach between $15 billion and $85 billion, while consumer medical applications could range from $25 billion to $60 billion by 2030-2040 [2] - The maturity of medical scenarios and the certainty of policy support in China provide a competitive advantage in the global BCI market [2] Group 3: Regulatory and Ethical Framework - China is actively exploring regulatory policies and standards for BCI technology, including the development of ethical guidelines and a standardization roadmap [4] - The National Technology Ethics Committee is working on ethical guidelines for BCI research, indicating a commitment to responsible development in this field [4]